TPI-1917-49
TPI-1917-49 is an agent that can cross the blood-brain barrier and reduce amyloid β (Aβ) . TPI-1917-49 reduces the production of Aβ peptide segments by promoting the non-amyloidogenic pathway of amyloid precursor protein (APP) (increasing the generation of sAPPα mediated by α-secretase) . TPI-1917-49 reduces amyloid plaques in mouse models. TPI-1917-49 can be used in Alzheimer's disease research[1].
Product Specifications
CAS Number
1250849-11-6
UNSPSC
12352005
Target
Amyloid-β
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Smiles
O=C(C1=CC=C(C(NC2=NC(C3=CC=CC(O)=C3)=CS2)=C1)N4CCN(CC4)C5=NC(C6=CC=CC(O)=C6)=CS5)N
Molecular Formula
C29H26N6O3S2
Molecular Weight
570.69
References & Citations
[1]Wang H, et al. Substituted dithiazole piperazine benzamides as novel amyloid beta peptide reducing agents. Bioorg Med Chem Lett. 2014 Sep 15;24 (18) :4384-4388.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
042121-PE 200 µL
SNX3, ID (SNX3, Sorting nexin-3, Protein SDP3) (PE) discontinued
Sign In for Pricing
View Details 
![MRPS11 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI2D1]](https://cdn.genprice.uk/products/937/6868c3a1994c49e6dc3fbbaa/imageurl/ta802879am.webp)
TA802879AM 100 µL
MRPS11 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI2D1]
Sign In for Pricing
View Details 